Invesco’s Milestone Scientific MLSS Stock Holding History

Invesco’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-36,728	Closed	-$131K	–	4005
2021 Q1	$131K	Buy	36,728 +1,545	+4%	+$5.29K	﹤0.01%	3734
2020 Q4	$75K	Buy	+35,183	New	+$61.9K	﹤0.01%	3686

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Invesco's MLSS Position: Q2 2021 in Review

Invesco sold out of Milestone Scientific (MLSS) in Q2 2021, closing a stake of 36,728 shares — an estimated $131K sold.

Invesco first reported a position in MLSS in Q4 2020 and held it in 2 quarters. The position peaked at $131K in Q1 2021. 45 funds tracked by Wall St. Rank hold MLSS as of Q2 2021.

Invesco reported no remaining Milestone Scientific position as of Q2 2021 after selling out during the quarter.
Invesco sold 36,728 Milestone Scientific shares in Q2 2021, an estimated $131K.
Invesco first reported a position in Milestone Scientific in Q4 2020 and held it in 2 quarters.
Invesco's Milestone Scientific position peaked at $131K in Q1 2021.
45 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.